Cart
sales@molnova.com
ICCB-19 HCl（750621-52-4 free base）
CAS No. 1803605-68-6
ICCB-19 HCl（750621-52-4 free base）( —— )
Catalog No. M23816 CAS No. 1803605-68-6
ICCB-19 HCl is an inhibitor of TRADD (TNFRSF1A Associated Via Death Domain).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 92 | In Stock |
|
| 50MG | 138 | In Stock |
|
| 100MG | 206 | In Stock |
|
| 200MG | 306 | In Stock |
|
| 500MG | 485 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameICCB-19 HCl（750621-52-4 free base）
-
NoteResearch use only, not for human use.
-
Brief DescriptionICCB-19 HCl is an inhibitor of TRADD (TNFRSF1A Associated Via Death Domain).
-
DescriptionICCB-19 HCl is an inhibitor of TRADD (TNFRSF1A Associated Via Death Domain). It binds to a pocket on the N-terminal TRAF2-binding domain of TRADD (TRADD-N), which interacts with the C-terminal domain (TRADD-C) and TRAF2 to modulate the ubiquitination of RIPK1 and beclin 1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTRADD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1803605-68-6
-
Formula Weight291.84
-
Molecular FormulaC12H22ClN3OS
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CCCC(CC1)NC(=O)CSC2=NCCN2.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu D , Zhao H , Jin M , et al. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis[J]. Nature, 2020, 587(7832):1-6.
molnova catalog
related products
-
Coenzyme FO
Coenzyme FO, a deazaflavin chromophore, is essential as a hydride acceptor/donor in the central methanogenic pathway .
-
Laminin (925-933)(TF...
Laminin (925-933) (TFA) is a peptide derived from residues 925-933 of the Laminin B1 chain that binds to the laminin receptor.
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
